J. Q. Cheng

发表

p16 alterations and deletion mapping of 9p21-p22 in malignant mesothelioma.

O. Olopade, J. Cheng, S. Jhanwar, 1994, Cancer research.

Phosphatidylinositol-3-OH Kinase (PI3K)/AKT2, activated in breast cancer, regulates and is induced by estrogen receptor alpha (ERalpha) via interaction between ERalpha and PI3K.

J E Paciga, D. Coppola, S. Nicosia, 2001, Cancer research.

High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas.

S. Jhanwar, J. Testa, B. Seizinger, 1995, Proceedings of the National Academy of Sciences of the United States of America.

Frequent mutations of NF2 and allelic loss from chromosome band 22q12 in malignant mesothelioma: Evidence for a two‐hit mechanism of NF2 inactivation

J. Cheng, S. Jhanwar, J. Testa, 1999, Genes, chromosomes & cancer.

The ERGB/Fli-1 gene: isolation and characterization of a new member of the family of human ETS transcription factors.

J. Testa, A. Seth, D. Watson, 1992, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

AKT2, a member of the protein kinase B family, is activated by growth factors, v-Ha-ras, and v-src through phosphatidylinositol 3-kinase in human ovarian epithelial cancer cells.

S. Nicosia, J. Cheng, R. Jove, 1998, Cancer research.

Deacetylation of cortactin by SIRT1 promotes cell migration

P. Kruk, S. Nicosia, J. Cheng, 2009, Oncogene.

Cloning, chromosomal localization and expression analysis of the mouse Akt2 oncogene.

J. Cheng, J. Testa, K. Walsh, 1995, Oncogene.

Homozygous deletions within 9p21-p22 identify a small critical region of chromosomal loss in human malignant mesotheliomas.

J. Cheng, S. Jhanwar, J. Testa, 1993, Cancer research.

Chromosome alterations in human small cell lung cancer: frequent involvement of 5q.

J. Testa, L. Doyle, I. Miura, 1992, Cancer research.

Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA.

J. Cheng, J. Testa, D. Watson, 1996, Proceedings of the National Academy of Sciences of the United States of America.

AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas.

J. Cheng, A. Godwin, J. Testa, 1992, Proceedings of the National Academy of Sciences of the United States of America.

RUNX3-mediated transcriptional inhibition of Akt suppresses tumorigenesis of human gastric cancer cells

M. Hsiao, P. Lu, Chau-Hwang Lee, 2012, Oncogene.

Structure, expression and chromosomal mapping of c-akt: relationship to v-akt and its implications.

J. Testa, T. Franke, A. Bellacosa, 1993, Oncogene.

Advances in the analysis of chromosome alterations in human lung carcinomas.

D. Bell, J. Testa, T. Taguchi, 1997, Cancer genetics and cytogenetics.

The p16 status of tumor cell lines identifies small molecule inhibitors specific for cyclin-dependent kinase 4.

F. Kaye, J. Testa, M. Kelley, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

A microdissection library of the rat renal carcinoma gene region.

S. Bohlander, D. Bell, J. Testa, 1995, Cytogenetics and cell genetics.

Ultraviolet irradiation- and dimethyl sulfoxide-induced telomerase activity in ovarian epithelial cell lines.

P. Kruk, J. Q. Cheng, M. Y. Alfonso-De Matte, 2001, Experimental cell research.

AKT1/PKBalpha kinase is frequently elevated in human cancers and its constitutive activation is required for oncogenic transformation in NIH3T3 cells.

J E Paciga, S. Nicosia, J. Cheng, 2001, The American journal of pathology.

Treatment of Ménétrier's disease with a monoclonal antibody against the epidermal growth factor receptor.

K. Washington, R. Coffey, J. Goldenring, 2000, The New England journal of medicine.

IKBKE is induced by STAT3 and tobacco carcinogen and determines chemosensitivity in non-small cell lung cancer

J. Cheng, S. Chellappan, Jian-ping Guo, 2013, Oncogene.